Valuation: Southern Acids (M)

Market Cap 414M 102M 87.72M 82.07M 75.13M 141M 9.8B 143M 970M 378M 4.92B 385M 376M 16.28B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -12.92M -3.2M -2.74M -2.57M -2.35M -4.41M -306M -4.46M -30.31M -11.82M -154M -12.02M -11.76M -509M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
1 day+0.33%
1 week+0.33%
Current month-1.63%
1 month-2.58%
3 months-3.51%
6 months-8.48%
Current year-5.03%
1 week 3
Extreme 3
3.12
1 month 3
Extreme 3
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 2015-07-14
Director of Finance/CFO 58 2013-09-30
Chief Tech/Sci/R&D Officer 38 2014-07-15
Director TitleAgeSince
Director/Board Member 66 2005-08-09
Director/Board Member 59 2012-03-19
Chairman 79 2015-07-14
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%+0.33%-10.12%-13.47% 102M
-0.31%+2.12%+31.93%+458.50% 5.92B
+1.28%+6.29%+34.58%+112.30% 1.88B
-0.11%+0.87%-6.47%+77.20% 838M
-2.89%-0.48%+25.97%+18.93% 598M
+2.64%+2.64%+48.09%+115.08% 589M
-5.24%+4.47%-20.65%-20.43% 564M
-11.78%+10.80%+56.62%+21.16% 503M
+0.14%+5.92%+12.70%+16.43% 417M
-0.26%+2.01%+5.99%+32.61% 294M
Average -1.62%+2.54%+17.86%+81.83% 1.17B
Weighted average by Cap. -0.73%+1.54%+26.94%+263.41%

Financials

2025 2026
Net sales 1.11B 274M 235M 220M 201M 377M 26.2B 382M 2.59B 1.01B 13.16B 1.03B 1.01B 43.54B 934M 231M 198M 185M 170M 318M 22.12B 322M 2.19B 854M 11.11B 868M 849M 36.75B
Net income 36.7M 9.09M 7.78M 7.28M 6.67M 12.51M 870M 12.68M 86.06M 33.56M 437M 34.12M 33.38M 1.44B 37.38M 9.26M 7.93M 7.42M 6.79M 12.74M 886M 12.91M 87.64M 34.18M 445M 34.75M 34M 1.47B
Net Debt -367M -90.85M -77.82M -72.81M -66.65M -125M -8.69B -127M -860M -335M -4.37B -341M -334M -14.44B -426M -106M -90.46M -84.64M -77.48M -145M -10.1B -147M -1B -390M -5.08B -397M -388M -16.79B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
26-08-20 MYR 3.020 +0.33% 28,500
26-08-19 MYR 3.010 +0.33% 31,100
26-08-18 MYR 3.000 -0.33% 16,300
26-08-17 MYR 3.010 0.00% 18,100
26-08-14 MYR 3.010 0.00% 28,100
  1. Stock Market
  2. Stocks
  3. 5134 Stock